Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

rhenium-SSS-lipiodol × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatocellular Carcinoma Non-resectable 1

Interventions

Specimen Handling 361 Magnetic Resonance Spectroscopy 295 pembrolizumab 281 Biopsy 231 Carboplatin 204 Cyclophosphamide 180 Cisplatin 163 Paclitaxel 150 Nivolumab 134 Gemcitabine 127 Radiotherapy 119 venetoclax 112 Bevacizumab 109 Dexamethasone 99 fludarabine 88 Rituximab 85 Pemetrexed 85 Oxaliplatin 84 Fluorouracil 84 Doxorubicin 81 durvalumab 80 Docetaxel 78 atezolizumab 77 Prednisone 74 Radiation 72 Lenalidomide 70 X-Rays 66 Leucovorin 64 Capecitabine 63 Vincristine 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05797870 2026-03-19

Lip-Re2

Center Eugene Marquis

Phase 2 Suspended

Gastrointestinal

Hepatocellular Carcinoma Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡